期刊文献+

P2X7受体在炎症性疾病中的作用及其机制 被引量:17

Effect of P2X7 receptor on inflammatory diseases and its mechanism
原文传递
导出
摘要 P2X7受体是以三磷酸腺苷(ATP)为配体的非选择性阳离子门控通道。P2X7受体在体内分布极为广泛,在多种炎性病理状态下表达上调。与P2X受体家族其它成员(P2X1-6)不同,长时间或高浓度激动剂激活后P2X7受体具有形成膜孔的特性,可诱导炎症介质的释放,这种特性与多种炎症性疾病密切相关。近年来,随着基因敲除P2X7受体的动物模型和特异性P2X7受体拮抗剂在炎症性疾病研究的广泛运用,P2X7受体可望成为炎症性疾病治疗的新靶点。本文对P2X7受体在炎症性疾病中的作用及其机制的研究进展作一综述。 P2X7 receptor is a member of ATP-gated non-selective cation channels. P2X7 receptor is widely distributed in vivo, and its expression is always observed to be up-regulated in the pathological inflammatory circumstances. P2X7 receptor has an unusual prop- erty of forming membrane pore during prolonged agonist exposure or high concentrations of agonist activation, different from other members of P2X receptors (P2X1-6). Because of this property, P2X7 receptor has been implicated in inflammatory cytokine release, and is closely related to inflammatory diseases. With the wide application of the P2X7-knockout animal model and specific P2X7 receptor antagonists in inflammatory disease research, P2X7 receptor is emerging as a new target for the treatment of inflammatory diseases. This article will review the recent progress regarding the effect of P2X7 receptor on inflammatory diseases and its mecha- nism.
作者 徐宏 梁尚栋
出处 《生理学报》 CAS CSCD 北大核心 2013年第2期244-252,共9页 Acta Physiologica Sinica
基金 supported by the grants from the National Natural Science Foundation of China(No.30860086 31060139and81171184) the Technology Pedestal and Society Development Project of Jiangxi Province China(No.2010BSA09500) the Young Scholars Science Foundation of Jiangxi Province China(No.20122BAB215005) the Youth Science Foundation of the Education Department of Jiangxi Province China(No.GJJ12149)
关键词 嘌呤2X7受体 三磷酸腺苷 炎症性疾病 白细胞介素-1Β 白细胞介素-18 P2X7 receptor ATP inflammatory disease IL-1β IL-18
  • 相关文献

参考文献61

  • 1Kaczmarek-Hajek K, Lorinczi E, Hausmann R, Nicke A. Molecular and functional properties of P2X receptors--recent progress and persisting challenges. Purinergic Signal 2012;8(3): 375-417.
  • 2Zhang J, Li X, Gao Y, Guo G, Xu C, Li G, Liu S, Huang A, Tu G, Peng H, Qiu S, Fan B, Zhu Q, Yu S, Zheng C, Liang S. Effects of puerarin on the inflammatory role of burn-related procedural pain mediated by P2X(7) receptors. Burns 2012; doi: 10.1016/j.burns.2012.08.013.
  • 3Liang S, Xu C, Li G, Gao Y. P2X receptors and modulation of pain transmission: focus on effects of drugs and com- pounds used in traditional Chinese medicine. Neurochem Int 2010; 57(7): 705-712.
  • 4Yu Y, Ugawa S, Ueda T, Ishida Y, Inoue K, Kyaw NA, Ume- mura A, Mase M, Yamada K, Shimada S. Cellular localiza- tion of P2X7 receptor mRNA in the rat brain. Brain Res 2008; 1194:45-55.
  • 5Ferrari D, Wesselborg S, Bauer MK, Schulze-OsthoffK. Ex- tracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF- kappaB p65. J Cell Biol 1997; 139(7): 1635-1643.
  • 6Skaper SD. Ion channels on microglia: therapeutic targets for neuroprotection. CNS Neurol Disord Drug Targets 2011; 10(1): 44-56.
  • 7Cotrina ML, Nedergaard M. Physiological and pathological functions of P2X7 receptor in the spinal cord. Purinergic Signal 2009: 5(2): 223-232.
  • 8Young MT, Pelegrin P, Surprenant A. Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP. Mol Pharrnacol 2007; 71(1): 92-100.
  • 9Donnelly-Roberts DL, Jarvis ME Discovery of P2X7 recep- tor-selective antagonists offers new insights into P2X7 re- ceptor function and indicates a role in chronic pain states. Br J Pharmacol 2007; 151(5): 571-579.
  • 10Michel AD, Chambers LJ, Clay WC, Condreay JP, Walter DS, Chessell IE Direct labelling of the human P2X7 recep- tor and identification of positive and negative cooperativity of binding. Br J Pharmacol 2007; 151(1): 103-114.

同被引文献105

引证文献17

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部